We treated tumor-bearing chimeric mice with Ad-Flt3L and Ad-TK 17 d post-tumor implantation and characterized the origin of tumor-infiltrating CD11c+ mDC 7 d after treatment. The gene discussed is TKT; the disease is neoplasm.